Physician profile
William D Suggs
NPI 1922180199
$4,763.74
in general payments reported to CMS, 2019-2025
41 companies · $1,097 in 2025
The $1,097 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $559 · 2021: $665 · 2022: $679 · 2023: $527 · 2024: $853 · 2025: $1,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,477.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $749.38 | 2020-2025 | Navicross, Metacross Otw, Azur Cx Detachable |
| Cook Medical LLC | $729.18 | 2019-2025 | Zenith, Zenith Spiral-Z, Advance |
| Boston Scientific Corporation | $459.60 | 2019-2025 | General - Catheters, General - Angioplasty |
| Endologix LLC | $334.27 | 2021 | |
| Smith+Nephew, INC. | $279.11 | 2019-2025 | Collagenase Santyl, Grafix Pl, Regranex |
| Organogenesis INC. | $278.81 | 2022-2025 | Apligraf, Puraply, Puraply Wound Matrix |
| Kerecis Limited | $260.53 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Novartis Pharmaceuticals Corporation | $197.57 | 2023-2025 | |
| Imbed Biosciences INC. | $137.08 | 2022 | |
| Resmed Corp | $110.96 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $83.47 | 2025 | Lifevest |
| W. L. Gore & Associates, INC. | $83.35 | 2025 | Gore Excluder Iliac Branch Endoprosthesis |
| Celgene Corporation | $75.15 | 2024-2025 | Camzyos |
| Tactile Systems Technology INC | $67.64 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Philips North America LLC | $67.42 | 2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $62.22 | 2023-2024 | Jeti Peripheral Catheter, Jot Dx |
| Atricure, INC. | $62.18 | 2022 | |
| Medtronic, INC. | $58.22 | 2021-2023 | Endurant Iis |
| Integra Lifesciences Corporation | $52.02 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Shockwave Medical, INC | $51.16 | 2022-2025 | |
| Angiodynamics, INC. | $48.93 | 2021 | |
| Solventum Corporation | $44.10 | 2024-2025 | Activ.A.C., Prevena, V.A.C.Ulta |
| Medicomp INC | $42.20 | 2024 | Telepatch Cardiac Monitor |
| Advanced Oxygen Therapy INC. | $40.68 | 2025 | Topical Oxygen Chamber For Extremities |
| Bard Peripheral Vascular, INC. | $34.88 | 2025 | Rotarexs 6 F X 135 Cm |
| Bioventus LLC | $32.99 | 2023 | |
| Imperative Care, INC | $31.79 | 2025 | Prodigy Catheter |
| Chiesi USA, INC. | $31.03 | 2021 | |
| Janssen Pharmaceuticals, INC | $27.53 | 2022 | |
| Convatec INC. | $24.39 | 2025 | |
| Merck Sharp & Dohme LLC | $21.36 | 2023 | Bridion |
| Silk Road Medical, INC. | $21.21 | 2019 | |
| Stryker Corporation | $20.92 | 2025 | Limflow System |
| Bridgebio Pharma, INC. | $20.77 | 2025 | Attruby |
| Hydrofera LLC | $19.37 | 2023 | Hydrofera Blue |
| E.R. Squibb & Sons, L.L.C. | $19.22 | 2022 | |
| Kci USA, INC. | $18.67 | 2023 | V.A.C. Dermatac, Activ.A.C., Kerramax Care |
| Acera Surgical, INC. | $17.90 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $17.25 | 2024 | Farxiga |
| Electromed, INC. | $15.43 | 2019 | |
| Reprise Biomedical, INC. | $13.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Suggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.